Literature DB >> 10701611

CT and MR imaging of hepatic metastases.

G T Sica1, H Ji, P R Ros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10701611     DOI： 10.2214/ajr.174.3.1740691

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  42 in total

1.  Quantitative liver lesion volume determination by nanoparticle-based SPECT.

Authors:  Dániel S Veres; Domokos Máthé; Ildikó Futó; Ildikó Horváth; Akos Balázs; Kinga Karlinger; Krisztián Szigeti
Journal:  Mol Imaging Biol       Date:  2014-04       Impact factor: 3.488

Review 2.  Solid liver masses: approach to management from the standpoint of a radiologist.

Authors:  Robert Garrett
Journal:  Curr Gastroenterol Rep       Date:  2013-12

3.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

4.  MRI with gadoxetate disodium for colorectal liver metastasis: is it the new "imaging modality of choice"?

Authors:  Shirali Patel; Susannah Cheek; Houssam Osman; D Rohan Jeyarajah
Journal:  J Gastrointest Surg       Date:  2014-10-16       Impact factor: 3.452

5.  Automated method for detection and segmentation of liver metastatic lesions in follow-up CT examinations.

Authors:  Avi Ben-Cohen; Eyal Klang; Idit Diamant; Noa Rozendorn; Michal Marianne Amitai; Hayit Greenspan
Journal:  J Med Imaging (Bellingham)       Date:  2015-08-19

Review 6.  Imaging of pathology involving the space around the hepatic veins: "perivenous pattern".

Authors:  Ali Devrim Karaosmanoğlu; Mehmet Ruhi Onur; Mustafa Nasuh Özmen; Deniz Akata; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

7.  90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT.

Authors:  Maren Bienert; Barry McCook; Brian I Carr; David A Geller; Mike Sheetz; Cecilia Tutor; Nikhil Amesur; Norbert Avril
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-17       Impact factor: 9.236

Review 8.  Imaging diagnosis of colorectal liver metastases.

Authors:  Ling-Hui Xu; San-Jun Cai; Guo-Xiang Cai; Wei-Jun Peng
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

9.  Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans.

Authors:  F Edward Boas; Aya Kamaya; Bao Do; Terry S Desser; Christopher F Beaulieu; Shreyas S Vasanawala; Gloria L Hwang; Daniel Y Sze
Journal:  J Digit Imaging       Date:  2015-04       Impact factor: 4.056

10.  Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.

Authors:  Allison F O'Neill; Jason L J Dearling; Yuchuan Wang; Tanya Tupper; Yanping Sun; Jon C Aster; Monica L Calicchio; Antonio R Perez-Atayde; Alan B Packard; Andrew L Kung
Journal:  Clin Cancer Res       Date:  2013-11-11       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.